Natixis Advisors, L.P. Dynavax Technologies Corp Transaction History
Natixis Advisors, L.P.
- $53.5 Billion
- Q4 2024
A detailed history of Natixis Advisors, L.P. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Natixis Advisors, L.P. holds 22,536 shares of DVAX stock, worth $285,981. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,536Holding current value
$285,981% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding DVAX
# of Institutions
285Shares Held
124MCall Options Held
474KPut Options Held
354K-
Black Rock Inc. New York, NY21.9MShares$278 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.5MShares$159 Million5.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$116 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.33MShares$106 Million7.62% of portfolio
-
State Street Corp Boston, MA7.69MShares$97.6 Million0.0% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.6B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...